About Moat Biotechnology
Moat Biotechnology is a private company based in Oklahoma City, Oklahoma, incorporated in 2022 in Delaware. It has reported $1,628,040 raised in three offerings on Form D since September 2022. Its chief executive is Scott Rollins.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 3, 2025 | Oct 20, 2025 | $26,400of $15.5M target | 1 | $26,400 | EquityRule 506(b) | Form D ↗ |
| Jan 10, 2023 | Feb 9, 2023 | $101,640of $20.0M target | 2 | $50,820 | EquityRule 506(b) | Form D ↗ |
| Jun 29, 2022 | Sep 21, 2022amended Oct 11, 2022 | $1,500,000fully sold | 2 | $750K | DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Total, three offerings | $1,628,040 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Moat Biotechnology's Form D filed Oct 20, 2025.
RR
Russell Rother
Executive officer, director and promoter
TC
Tetherex Pharmaceuticals Corporation
Promoter
MA
Michael Moradi-Araghi
Director
SR
Scott Rollins
CEO and director
TF
Todd Foley
Director
PJ
Phillip Jones
Director
Earlier filings also listed Richard Alvarez (executive officer, last listed Feb 2023) and Philip Jones (director, last listed Feb 2023).